logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabVitiligo and worsening of hypothyroidism following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2021年 / 1886卷 / 1期
关键词:
D O I:
10.1007/s40278-021-07503-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:238 / 238
相关论文
共 50 条
  • [41] SirolimusNeutropenia following off-label use: case report
    Reactions Weekly, 2023, 1960 (1) : 394 - 394
  • [42] RisperidonePancreatitis following off-label use: case report
    Reactions Weekly, 2022, 1934 (1) : 378 - 378
  • [43] TemozolomideThrombocytopenia following off-label use: case report
    Reactions Weekly, 2025, 2040 (1) : 934 - 934
  • [44] CyclophosphamideMyelosuppression following off-label use: case report
    Reactions Weekly, 2020, 1835 (1) : 116 - 116
  • [45] DenosumabHypocalcaemia following off-label use: case report
    Reactions Weekly, 2022, 1923 (1) : 178 - 178
  • [46] DimeticoneGranuloma following off-label use: case report
    Reactions Weekly, 2023, 1980 (1) : 150 - 150
  • [47] NalbuphineBradycardia following an off-label use: case report
    Reactions Weekly, 2019, 1753 (1) : 255 - 255
  • [48] SildenafilHypotension following off-label use: case report
    Reactions Weekly, 2025, 2045 (1) : 376 - 376
  • [49] DaratumumabHypogammaglobulinemia following off-label use: case report
    Reactions Weekly, 2020, 1802 (1) : 114 - 114
  • [50] DapsoneMethaemoglobinaemia following off-label use: case report
    Reactions Weekly, 2021, 1843 (1) : 130 - 130
← 12345 →